Oral bioavailability enhancement through supersaturation: an update and meta-analysis

References

• Frank KJ, Rosenblatt KM, Westedt U, et al. Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement. Int J Pharm. 2012;437:288–293.
   PubMed Web of Science ®Google Scholar
• Guzmán HR, Tawa M, Zhang Z, et al. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations. J Pharm Sci. 2007;96:2686–2702.
   PubMed Web of Science ®Google Scholar
• Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 2009;98:2549–2572.
   PubMed Web of Science ®Google Scholar
• Kawakami K. Theory and practice of supersaturatable formulations for poorly soluble drugs. Ther Deliv. 2015;6:339–352.
   PubMed Web of Science ®Google Scholar
• Sun DD, Lee PI. Haste makes waste: the interplay between dissolution and precipitation of supersaturating formulations. AAPS J. 2015;17:1317–1326.
   PubMed Web of Science ®Google Scholar
• Xu S, Dai W-G. Drug precipitation inhibitors in supersaturable formulations. Int J Pharm. 2013;453:36–43.
   PubMed Web of Science ®Google Scholar
• Kawakami K. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv Drug Deliv Rev. 2012;64:480–495.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci. 2012;101:3019–3032.
   PubMed Web of Science ®Google Scholar
• Lee TW-Y, Boersen NA, Hui H-W, et al. Oral delivery of poorly soluble compounds by supersaturated systems. Ther Deliv. 2011;2:685–690.
   PubMedGoogle Scholar
• Greco K, Bogner R. Solution-mediated phase transformation: significance during dissolution and implications for bioavailability. J Pharm Sci. 2012;101:2996–3018.
   PubMed Web of Science ®Google Scholar
• Griffin B. Advances in lipid-based formulations: overcoming the challenge of low bioavailability for poorly water soluble drug compounds. Am Pharm Rev. 2012;15:41–47.
   Google Scholar
• da Costa Mathews C, Sugano K. Supersaturable formulations. Drug Deliv Syst. 2010;25:371–374.
   Google Scholar
• Warren DB, Benameur H, Porter CJH, et al. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility. J Drug Target. 2010;18:704–731.
   PubMed Web of Science ®Google Scholar
• He Y, Ho C. Amorphous solid dispersions: utilization and challenges in drug discovery and development. J Pharm Sci. 2015;104:3237–3258.
   PubMed Web of Science ®Google Scholar
• Newman A, Nagapudi K, Wenslow R. Amorphous solid dispersions: a robust platform to address bioavailability challenges. Ther Deliv. 2015;6:247–261.
   PubMed Web of Science ®Google Scholar
• Leone F, Cavalli R. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations. Exp Opin Drug Deliv. 2015;12:1607–1625.
   PubMed Web of Science ®Google Scholar
• Dokania S, Joshi AK. Self-microemulsifying drug delivery system (SMEDDS) – challenges and road ahead. Drug Deliv. 2015;22:675–690.
   PubMed Web of Science ®Google Scholar
• Saluja V, Arora S, Goyal S. Self-emulsifying lipid formulation: an overview. Curr Drug Deliv. 2015;12:166–176.
   PubMed Web of Science ®Google Scholar
• Williams HD, Trevaskis NL, Yeap YY, et al. Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway. Pharm Res. 2013;30:2976–2992.
   PubMed Web of Science ®Google Scholar
• Démuth B, Nagy ZK, Balogh A, et al. Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations. Int J Pharm. 2015;486:268–286.
   PubMed Web of Science ®Google Scholar
• Sun DD, Lee PI. Crosslinked hydrogels – a promising class of insoluble solid molecular dispersion carriers for enhancing the delivery of poorly soluble drugs. Acta Pharm Sin B. 2014;4:26–36.
   PubMed Web of Science ®Google Scholar
• Pawar VK, Singh Y, Meher JG, et al. Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery. J Control Release. 2014;183:51–66.
   PubMed Web of Science ®Google Scholar
• Tarate B, Chavan R, Bansal A. Oral solid self-emulsifying formulations: a patent review. Recent Pat Drug Del Formul. 2014;8:126–143.
   PubMedGoogle Scholar
• Li Y, Pang H, Guo Z, et al. Interactions between drugs and polymers influencing hot melt extrusion. J Pharm Pharmacol. 2014;66:148–166.
   PubMed Web of Science ®Google Scholar
• Speybroeck M, Mellaerts R, Martens JA, et al. Ordered mesoporous silica for the delivery of poorly soluble drugs. In: Wilson GC, Crowley JP, editors. Controlled release in oral drug delivery. Boston (MA): Springer US; 2011. p. 203–219.
   Google Scholar
• Marthur V, Satrawala Y, Rajput MS. Biopharmaceutical performance and stability of co-crystal. Int J Pharm Frontier Res. 2011;1:135–145.
   Google Scholar
• Stappaerts J, Brouwers J, Annaert P, et al. In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities. Int J Pharm. 2015;478:665–681.
   PubMed Web of Science ®Google Scholar
• Kostewicz ES, Abrahamsson B, Brewster M, et al. In vitro models for the prediction of in vivo performance of oral dosage forms. Eur J Pharm Sci. 2014;57:342–366.
   PubMed Web of Science ®Google Scholar
• Bevernage J, Brouwers J, Brewster ME, et al. Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues. Int J Pharm. 2013;453:25–35.
   PubMed Web of Science ®Google Scholar
• Buckley ST, Frank KJ, Fricker G, et al. Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”. Eur J Pharm Sci. 2013;50:8–16.
   PubMed Web of Science ®Google Scholar
• Gao P, Shi Y. Characterization of supersaturatable formulations for improved absorption of poorly soluble drugs. AAPS J. 2012;14:703–713.
   PubMed Web of Science ®Google Scholar
• Augustijns P, Brewster ME. Supersaturating drug delivery systems: fast is not necessarily good enough. J Pharm Sci. 2012;101:7–9.
   PubMed Web of Science ®Google Scholar
• Newman A, Knipp G, Zografi G. Assessing the performance of amorphous solid dispersions. J Pharm Sci. 2012;101:1355–1377.
   PubMed Web of Science ®Google Scholar
• Williams HD, Trevaskis NL, Charman SA, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev 2013;65:315–499.
   PubMed Web of Science ®Google Scholar
• Fong SYK, Brandl M, Bauer-Brandl A. Phospholipid-based solid drug formulations for oral bioavailability enhancement: a meta-analysis. Eur J Pharm Sci. 2015;80:89–110.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558.
   PubMed Web of Science ®Google Scholar
• Neyeloff J, Fuchs S, Moreira L. Meta-analyses and Forest plots using a Microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes. 2012;5:52.
   PubMedGoogle Scholar
• Frank KJ, Westedt U, Rosenblatt KM, et al. What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion? J Pharm Sci. 2014;103:1779–1786.
   PubMed Web of Science ®Google Scholar
• Shi C, Tong Q, Fang J, et al. Preparation, characterization and in vivo studies of amorphous solid dispersion of berberine with hydrogenated phosphatidylcholine. Eur J Pharm Sci. 2015;74:11–17.
   PubMed Web of Science ®Google Scholar
• Zhaojie M, Ming Z, Shengnan W, et al. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability. Int J Pharm. 2014;467:50–59.
   PubMed Web of Science ®Google Scholar
• Ueda K, Higashi K, Limwikrant W, et al. Mechanistic differences in permeation behavior of supersaturated and solubilized solutions of carbamazepine revealed by nuclear magnetic resonance measurements. Mol Pharm. 2012;9:3023–3033.
   PubMed Web of Science ®Google Scholar
• Tsinman O, Tsinman K, Ali S. Excipient update – soluplus: an understanding of supersaturation from amorphous solid dispersions. Drug Dev Deliv. 2015;15:20–26.
   Google Scholar
• Beig A, Miller JM, Lindley D, et al. Head-to-head comparison of different solubility-enabling formulations of etoposide and their consequent solubility-permeability interplay. J Pharm Sci. 2015;104:2941–2947.
   PubMed Web of Science ®Google Scholar
• Song WH, Yeom DW, Lee DH, et al. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system. Arch Pharmacal Res. 2013;37:626–635.
   PubMed Web of Science ®Google Scholar
• Kataoka M, Sugano K, Mathews C, et al. Application of dissolution/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development. Pharm Res. 2011;29:1485–1494.
   PubMed Web of Science ®Google Scholar
• Zhou H, Wan J, Wu L, et al. A new strategy for enhancing the oral bioavailability of drugs with poor water-solubility and low liposolubility based on phospholipid complex and supersaturated SEDDS. PLoS One. 2013;8:e84530.
   PubMed Web of Science ®Google Scholar
• Nan Z, Lijun G, Tao W, et al. Evaluation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation in-vitro and in-vivo. Iran J Pharm Sci. 2012;11:257–264.
   Google Scholar
• Bandyopadhyay S, Katare OP, Singh B. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Exp Opin Drug Deliv. 2014;11:479–492.
   PubMed Web of Science ®Google Scholar
• Tran TH, Guo Y, Song D, et al. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability. J Pharm Sci. 2014;103:840–852.
   PubMed Web of Science ®Google Scholar
• Di Cagno M, Luppi B. Drug “supersaturation” states induced by polymeric micelles and liposomes: a mechanistic investigation into permeability enhancements. Eur J Pharm Sci. 2013;48:775–780.
   PubMed Web of Science ®Google Scholar
• Pu X, Sun J, Han J, et al. Nanosuspensions of 10-hydroxycamptothecin that can maintain high and extended supersaturation to enhance oral absorption: preparation, characterization and in vitro/in vivo evaluation. J Nanoparticle Res. 2013;15:1–13.
   Web of Science ®Google Scholar
• Ueda K, Higashi K, Yamamoto K, et al. In situ molecular elucidation of drug supersaturation achieved by nano-sizing and amorphization of poorly water-soluble drug. Eur J Pharm Sci. 2015;77:79–89.
   PubMed Web of Science ®Google Scholar
• Nkansah P, Antipas A, Lu Y, et al. Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs. J Control Release. 2013;169:150–161.
   PubMed Web of Science ®Google Scholar
• Stappaerts J, Geboers S, Snoeys J, et al. Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: in vitro, rat in situ and human in vivo studies. Eur J Pharm Biopharm. 2015;90:1–7.
   PubMed Web of Science ®Google Scholar
• Balk A, Widmer T, Wiest J, et al. Ionic liquid versus prodrug strategy to address formulation challenges. Pharm Res. 2014;32:2154–2167.
   PubMed Web of Science ®Google Scholar
• Ha ES, Baek IH, Cho W, et al. Preparation and evaluation of solid dispersion of atorvastatin calcium with Soluplus(R) by spray drying technique. Chem Pharm Bull. 2014;62:545–551.
   PubMed Web of Science ®Google Scholar
• Bennett RC, Brough C, Miller DA, et al. Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol dispersing: approaches to enhance solubility of a poorly water-soluble gum extract. Drug Dev Ind Pharm. 2015;41:382–397.
   PubMed Web of Science ®Google Scholar
• Jang D-J, Sim T, Oh E. Formulation and optimization of spray-dried amlodipine solid dispersion for enhanced oral absorption. Drug Dev Ind Pharm. 2013;39:1133–1141.
   PubMed Web of Science ®Google Scholar
• Ranzani LS, Font J, Galimany F, et al. Enhanced in vivo absorption of CB-1 antagonist in rats via solid solutions prepared by hot-melt extrusion. Drug Dev Ind Pharm. 2011;37:694–701.
   PubMed Web of Science ®Google Scholar
• De Jaeghere W, De Beer T, Van Bocxlaer J, et al. Hot-melt extrusion of polyvinyl alcohol for oral immediate release applications. Int J Pharm. 2015;492:1–9.
   PubMed Web of Science ®Google Scholar
• Lohani S, Cooper H, Jin X, et al. Physicochemical properties, form, and formulation selection strategy for a biopharmaceutical classification system class II preclinical drug candidate. J Pharm Sci. 2014;103:3007–3021.
   PubMed Web of Science ®Google Scholar
• Beak I-H, Kim M-S. Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions. Chem Pharm Bull. 2012;60:1468–1473.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li H, Lang B, et al. Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing. Eur J Pharm Biopharm. 2012;82:534–544.
   PubMed Web of Science ®Google Scholar
• Chiang P-C, Cui Y, Ran Y, et al. In vitro and in vivo evaluation of amorphous solid dispersions generated by different bench-scale processes, using griseofulvin as a model compound. AAPS J. 2013;15:608–617.
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Brough C, Miller DA, et al. Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion. J Pharm Sci. 2010;99:1239–1253.
   PubMed Web of Science ®Google Scholar
• Kojima T, Higashi K, Suzuki T, et al. Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT® EPO. Pharm Res. 2012;29:2777–2791.
   PubMed Web of Science ®Google Scholar
• Kim M-S, Kim J-S, Cho W, et al. Supersaturatable formulations for the enhanced oral absorption of sirolimus. Int J Pharm. 2013;445:108–116.
   PubMed Web of Science ®Google Scholar
• Shah N, Iyer RM, Mair H-J, et al. Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process. J Pharm Sci. 2013;102:967–981.
   PubMed Web of Science ®Google Scholar
• Shi Y, Gao P, Gong Y, et al. Application of a biphasic test for characterization of in vitro drug release of immediate release formulations of celecoxib and its relevance to in vivo absorption. Mol Pharm. 2010;7:1458–1465.
   PubMed Web of Science ®Google Scholar
• Mukherjee T, Plakogiannis FM. Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole. J Pharm Pharmacol. 2010;62:1112–1120.
   PubMed Web of Science ®Google Scholar
• Tian X, Dong-Qin Q. Assessment of a supersaturated self-microemulsifying formulation of biphenyl dimethyl dicarboxylate in vitro and in vivo. Chin Pharm J. 2011;46:600–604.
   Google Scholar
• Chen Y, Chen C, Zheng J, et al. Development of a solid supersaturatable self-emulsifying drug delivery system of docetaxel with improved dissolution and bioavailability. Biol Pharm Bull. 2011;34:278–286.
   PubMed Web of Science ®Google Scholar
• Lee DH, Yeom DW, Song YS, et al. Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS). Int J Pharm. 2015;478:341–347.
   PubMed Web of Science ®Google Scholar
• Sha XY, Chen YZ, Wu J, et al. Preparation of paclitaxel supersaturatable self-microemulsifying drug delivery system and its pharmacokinetics in rats. Pharm Care Res. 2011;11:138–140.
   Google Scholar
• Thomas N, Richter K, Pedersen TB, et al. In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate. AAPS J. 2014;16:539–549.
   PubMed Web of Science ®Google Scholar
• Chavan RB, Modi SR, Bansal AK. Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib. Int J Pharm. 2015;495:374–384.
   PubMed Web of Science ®Google Scholar
• Kim M-S, Ha E-S, Choo G-H, et al. Preparation and in vivo evaluation of a dutasteride-loaded solid-supersaturatable self-microemulsifying drug delivery system. Int J Mol Sci. 2015;16:10821–10833.
   PubMed Web of Science ®Google Scholar
• Dash RN, Mohammed H, Humaira T, et al. Solid supersaturatable self-nanoemulsifying drug delivery systems for improved dissolution, absorption and pharmacodynamic effects of glipizide. J Drug Delivery Sci Technol. 2015;28:28–36.
   Web of Science ®Google Scholar
• Kim M-S. Evaluation of in vitro dissolution and in vivo oral absorption of dutasteride-loaded eudragit E nanoparticles. Drug Res. 2013;63:326–330.
   Google Scholar
• Ochi M, Kawachi T, Toita E, et al. Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors. Int J Pharm. 2014;474:151–156.
   PubMed Web of Science ®Google Scholar
• Kim M-S, Kim J-S, Park HJ, et al. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process. Int J Nanomed. 2011;6:2997–3009.
   PubMed Web of Science ®Google Scholar
• Miller MA, DiNunzio J, Matteucci ME, et al. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability. Drug Dev Ind Pharm. 2012;38:557–570.
   PubMed Web of Science ®Google Scholar
• Kim M-S, Baek I-H. Fabrication and evaluation of valsartan–polymer– surfactant composite nanoparticles by using the supercritical antisolvent process. Int J Nanomed. 2014;9:5167–5176.
   PubMed Web of Science ®Google Scholar
• Van Speybroeck M, Mellaerts R, Thi TD, et al. Preventing release in the acidic environment of the stomach via occlusion in ordered mesoporous silica enhances the absorption of poorly soluble weakly acidic drugs. J Pharm Sci. 2011;100:4864–4876.
   PubMed Web of Science ®Google Scholar
• Van Speybroeck M, Mellaerts R, Mols R, et al. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. Eur J Pharm Sci. 2010;41:623–630.
   PubMed Web of Science ®Google Scholar
• Van Speybroeck M, Mols R, Mellaerts R, et al. Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole. Eur J Pharm Biopharm. 2010;75:354–365.
   PubMed Web of Science ®Google Scholar
• Jia Z, Lin P, Xiang Y, et al. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate. Eur J Pharm Biopharm. 2011;79:126–134.
   PubMed Web of Science ®Google Scholar
• Kim M-S. Soluplus-coated colloidal silica nanomatrix system for enhanced supersaturation and oral absorption of poorly water-soluble drugs. Artif Cells Nanomed Biotechnol. 2013;41:363–367.
   PubMed Web of Science ®Google Scholar
• Rao S, Tan A, Boyd BJ, et al. Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin. Nanomedicine. 2014;9:2745–2759.
   PubMed Web of Science ®Google Scholar
• Tan A, Davey AK, Prestidge CA. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib. Pharm Res. 2011;28:2273–2287.
   PubMed Web of Science ®Google Scholar
• Ganesh M, Jeon UJ, Ubaidulla U, et al. Chitosan cocrystals embedded alginate beads for enhancing the solubility and bioavailability of aceclofenac. Int J Biol Macromol. 2015;74:310–317.
   PubMed Web of Science ®Google Scholar
• Childs SL, Kandi P, Lingireddy SR. Formulation of a danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability. Mol Pharm. 2013;10:3112–3127.
   PubMed Web of Science ®Google Scholar
• Takano R, Takata N, Saito R, et al. Quantitative analysis of the effect of supersaturation on in vivo drug absorption. Mol Pharm. 2010;7:1431–1440.
   PubMed Web of Science ®Google Scholar
• Terebetski JL, Cummings JJ, Fauty SE, et al. Combined use of crystalline sodium salt and polymeric precipitation inhibitors to improve pharmacokinetic profile of ibuprofen through supersaturation. AAPS PharmSciTech. 2014;15:1334–1344.
   PubMed Web of Science ®Google Scholar
• Onoue S, Kojo Y, Suzuki H, et al. Development of novel solid dispersion of tranilast using amphiphilic block copolymer for improved oral bioavailability. Int J Pharm. 2013;452:220–226.
   PubMed Web of Science ®Google Scholar
• Desai S, Disouza J, Sable A, et al. Development of orodispersible tablet of atorvastatin calcium using hot melt extrusion. Drug Deliv Lett. 2015;5:19–30.
   Google Scholar
• Mosharraf M, Nyström C. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs. Int J Pharm. 1995;122:35–47.
   Web of Science ®Google Scholar
• Matteucci ME, Brettmann BK, Rogers TL, et al. Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol Pharm. 2007;4:782–793.
   PubMed Web of Science ®Google Scholar
• Frank KJ, Westedt U, Rosenblatt KM, et al. The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility. Int J Nanomed. 2012;7:5757–5768.
   PubMed Web of Science ®Google Scholar
• Raina SA, Zhang GGZ, Alonzo DE, et al. Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs. J Pharm Sci. 2014;103:2736–2748.
   PubMed Web of Science ®Google Scholar
• Polster CS, Wu S-J, Gueorguieva I, et al. Mechanism for enhanced absorption of a solid dispersion formulation of LY2300559 using the artificial stomach duodenum model. Mol Pharm. 2015;12:1131–1140.
   PubMed Web of Science ®Google Scholar
• Narang AS, Badawy S, Ye Q, et al. Role of self-association and supersaturation in oral absorption of a poorly soluble weakly basic drug. Pharm Res. 2015;32:2579–2594.
   PubMed Web of Science ®Google Scholar
• Williams HD, Sassene P, Kleberg K, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations. Pharm Res. 2013;30:3059–3076.
   PubMed Web of Science ®Google Scholar
• Qian F, Wang J, Hartley R, et al. Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications. Pharm Res. 2012;29:2766–2776.
   Web of Science ®Google Scholar
• Do TT, Van Speybroeck M, Mols R, et al. The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate. Int J Pharm. 2011;414:118–124.
   PubMed Web of Science ®Google Scholar
• Kanzer J, Hupfeld S, Vasskog T, et al. In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionation. J Pharm Biomed Anal. 2010;53:359–365.
   PubMed Web of Science ®Google Scholar
• Fong SYK, Ibisogly A, Bauer-Brandl A. Solubility enhancement of BCS class II drug by solid phospholipid dispersions: spray drying versus freeze-drying. Int J Pharm. 2015;496:382–391.
   PubMed Web of Science ®Google Scholar
• Shah KB, Patel PG, Khairuzzaman A, et al. An improved method for the characterization of supersaturation and precipitation of poorly soluble drugs using pulsatile microdialysis (PMD). Int J Pharm. 2014;468:64–74.
   PubMed Web of Science ®Google Scholar
• Fong SYK, Martins SM, Brandl M, et al. Solid phospholipid dispersions for oral delivery of poorly soluble drugs: investigation into celecoxib incorporation and solubility-in vitro permeability enhancement. J Pharm Sci. 2016;105:1113–1123.
   PubMed Web of Science ®Google Scholar
• Bevernage J, Brouwers J, Annaert P, et al. Drug precipitation–permeation interplay: supersaturation in an absorptive environment. Eur J Pharm Biopharm. 2012;82:424–428.
   PubMed Web of Science ®Google Scholar
• Mosquera-Giraldo LI, Taylor LS. Glass–liquid phase separation in highly supersaturated aqueous solutions of telaprevir. Mol Pharm. 2015;12:496–503.
   PubMed Web of Science ®Google Scholar
• Yu H, Xia D, Zhu Q, et al. Supersaturated polymeric micelles for oral cyclosporine A delivery. Eur J Pharm Biopharm. 2013;85:1325–1336.
   PubMed Web of Science ®Google Scholar
• Ginski MJ, Polli JE. Prediction of dissolution–absorption relationships from a dissolution/Caco-2 system. Int J Pharm. 1999;177:117–125.
   PubMed Web of Science ®Google Scholar
• Kataoka M, Masaoka Y, Yamazaki Y, et al. In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs. Pharm Res. 2003;20:1674–1680.
   PubMed Web of Science ®Google Scholar
• Motz SA, Schaefer UF, Balbach S, et al. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell. Eur J Pharm Biopharm. 2007;66:286–295.
   PubMed Web of Science ®Google Scholar
• Buch P, Langguth P, Kataoka M, et al. IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system. J Pharm Sci. 2009;98:2001–2009.
   PubMed Web of Science ®Google Scholar
• Miyaji Y, Fujii Y, Takeyama S, et al. Advantage of the dissolution/permeation system for estimating oral absorption of drug candidates in the drug discovery stage. Mol Pharm. 2016;13:1564–1574.
   PubMed Web of Science ®Google Scholar
• Motz AS, Bur M, Schaefer FU, et al. Instrumented in vitro approaches to assess epithelial permeability of drugs from pharmaceutical formulations. In: Ehrhardt C, Kim K-J, editors. Drug absorption studies: in situ, in vitro and in silico models. Boston (MA): Springer US; 2008. p. 430–455.
   Google Scholar
• Petrakis O, Vertzoni M, Angelou A, et al. Identification of key factors affecting the oral absorption of salts of lipophilic weak acids: a case example. J Pharm Pharmacol. 2015;67:56–67.
   PubMed Web of Science ®Google Scholar
• Gao Y, Carr RA, Spence JK, et al. A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling. Mol Pharm. 2010;7:1516–1526.
   PubMed Web of Science ®Google Scholar
• Stillhart C, Imanidis G, Kuentz M. Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line Raman spectroscopy and mathematical modeling. Pharm Res. 2013;30:3114–3130.
   PubMed Web of Science ®Google Scholar
• Kleppe MS, Forney-Stevens KM, Haskell RJ, et al. Mathematical models to explore potential effects of supersaturation and precipitation on oral bioavailability of poorly soluble drugs. AAPS J. 2015;17:902–917.
   PubMed Web of Science ®Google Scholar
• Charkoftaki G, Dokoumetzidis A, Valsami G, et al. Supersaturated dissolution data and their interpretation: the TPGS–carbamazepine model case. J Pharm Pharmacol. 2011;63:352–361.
   PubMed Web of Science ®Google Scholar
• Woods D, Trewheellar K. Medline and Embase complement each other in literature searches. BMJ. 1998;316:1166–66.
   PubMed Web of Science ®Google Scholar
• Kleijnen J, Knipschild P. The comprehensiveness of Medline and Embase computer searches. Pharm Weekbl. 1992;14:316–320.
   PubMed Web of Science ®Google Scholar